Table 1.
Aim | Data type | Indicators | Data Source | Purpose | Collected from | Timeline |
---|---|---|---|---|---|---|
Aim 1 | Administrative Data | SDOH service implementation progress and outputs (e.g., rates of SDOH interventions) | Spreadsheet | To monitor progress and outputs | Pharmacist | Throughout the implementation period |
Aim 2 | Surveys | Clinic Satisfaction | Satisfaction Survey (created for study, alpha = 0.96; 3 items; 6-point scale, from “strongly disagree” to “strongly agree”) | To assess satisfaction of the clinic team members with the service | Clinic liaisons, staff and providers (N = 11/16, or response rate = 69%) | After the first 3 months of implementation |
Perceived Benefits | Perceived Benefits Survey1 (4 items; 6-point scale, from “strongly disagree” to “strongly agree”) | To assess perceived benefits of the service from the clinics' perspective | ||||
Service Acceptability | Service Acceptability Measure from IOQ2 (7 items; 6-point scale, from “strongly disagree” to “strongly agree”) | To assess acceptability of the service from the clinics' perspective | ||||
Service Appropriateness | Service Appropriateness Measure from IOQ2 (6 items, response range from 1 to 5, from “not at all” to “extremely”) | To assess integration and alignment of the service with the clinic and its practice | ||||
Service Feasibility | Adapted Service Feasibility Survey from IOQ2(7 items; 6-point scale, from “strongly disagree” to “strongly agree”) | To assess practicality of implementing the service | ||||
Patient Satisfaction/Experience | Adapted Patient Satisfaction/Experience3 (Satisfaction: 1 item; 5-point scale, from “very poor” to “excellent”; Experience: 14 items; 5-point scale from "strongly disagree" to "stronly agree") | To assess patient satisfaction and experience with the pharmacist and visits | Patients (N = 10/12 or response rate = 83%) | At end of the implementation period | ||
Interviews | Clinics' overall experience with the service | Interview transcripts | To assess the clinics' overall experience with the telepharmacy service | Clinic liaisons (N = 3/3 or response rate = 100%) | After the first 3 months of implementation | |
Aim 3 | Surveys | Patient Quality of life | Adapted from Diabetes Quality of Life Survey4 (satisfaction with diabetes control: 6 items, 5-point scale, from “very dissatisfied” to “very satisfied”; and adherence to self-care regimen: 3 items, 5-point scale, from “never” to “all the time”) | To assess patients' satisfaction with diabetes control and adherence to self-care regimen | Patients (N = 10/12 or response rate = 83%) | At end of the implementation period |
SDOH Self-Efficacy | SDOH Self-Efficacy survey (created for study, alpha = 0.94) (5 items; 5-point scale, from “strongly disagree” to “strongly agree”) | To assess confidence with SDOH needs being met and ability to problem-solve, access support and resources, and access medications |
Venkatesh V, Bala H. Technology Acceptance Model 3 and a Research Agenda on Interventions Subject Areas: Design Characteristics, Interventions. Decis Sci [Internet]. 2008;39(2):273–315. doi.org/10.1111/j.1540-5915.2008.00192.x
Livet M, Blanchard C, Richard C, et al. Measuring implementation of medication optimization services: Development and validation of an implementation outcomes questionnaire. Res Soc Adm Pharm. 2021 (December 2020). doi.org/10.1016/j.sapharm.2021.01.001
Shin J, Moczygemba LR, Barner JC, Garza A, Linedecker-Smith S, Srinivasa M. Patient experience with clinical pharmacist services in Travis County Federally Qualified Health Centers. Pharmacy Practice 2020 (Apr-Jun);18(2):1751. doi.org/10.18549/PharmPract.2020.2.1751
Burroughs J, Mick D. Exploring Antecedents and Consequences of Consumer Creativity in a Problem-Solving Context, Journal of Consumer Research. 2004;31(2):402–411. doi.org/10.1086/422118